ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
56 announcements
Star Health and Allied Insurance Company Ltd has scheduled a board meeting on October 27, 2026, to approve its quarterly and half-yearly financial results.
Star Health has withdrawn its application for reclassification of three promoter group entities. The Board of Directors approved this withdrawal via circular resolution.
Star Health has withdrawn its reclassification application for IDC Electronics Limited, a promoter group entity. Entities that have ceased to exist are also removed from promoter group.
Star Health delivered strong Q1 FY27 results with GWP growing 19% YoY to ₹4,287 Cr and PAT rising 25% to ₹550 Cr. Strategy focuses on proprietary distribution and underwriting profitability.
Star Health and Allied Insurance has appointed Mr. Utpal Hemendra Sheth as a Non-Executive Nominee Director, representing Sitara Partners LLP, effective August 28, 2026.
Star Health held its 21st Annual General Meeting on August 28, 2026. The meeting covered the adoption of financial statements and the appointment of directors.
Star Health received directions from IRDAI regarding policy portability and claim settlements for FY 2024-25 and FY 2025-26. The company expects limited financial impact from these compliance reviews.
Star Health received requests to reclassify nine entities, including AERS Consultancy and Alchemy Capital, from the Promoter Group to the Public category.
Star Health Q1 FY27 results show strong underwriting profitability and a 25% YoY PAT increase. Strategy focuses on proprietary distribution, retail health leadership, and digital/AI-driven claims precision.
Star Health has submitted an application to the stock exchanges seeking approval for the reclassification of members of its Promoter Group to the Public category.
Star Health and Allied Insurance Company has submitted its Integrated Annual Report for the financial year ended March 31, 2026, as per regulatory requirements.
Star Health and Allied Insurance Company Limited filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, disclosing its operational and sustainability performance.
Star Health and Allied Insurance has issued a notice for its 21st Annual General Meeting, scheduled to be held on August 28, 2026.
Star Health marked its 20th anniversary with strong Q1 FY27 results, showing 19% GWP growth and consistent underwriting profitability despite a higher claims season.
Star Health delivered strong Q1 FY27 results with 19% GWP growth and significantly improved profitability, driven by its proprietary distribution channels and digital initiatives.
Star Health reported a Q1 FY27 Profit After Tax of ₹550 Crore, reflecting a 25% year-on-year growth. The insurer also announced significant improvements in underwriting profitability.
Star Health filed a security cover certificate as per SEBI regulations, declaring 'NIL' status for its listed non-convertible debentures for the quarter ended June 30, 2026.
Star Health and Allied Insurance Company Ltd reported revenue from operations of ₹4,917 Cr (+13.4% YoY) and net profit of ₹549.7 Cr (+25.4% YoY) for Q1 FY27.
Star Health reported promoter group changes following the share transmission from the late Rakesh Jhunjhunwala and the formal removal of two entities from the promoter group list.
Star Health clarified that the change in promoter shareholding resulted from the transmission of shares from the estate of Late Mr. Rakesh Jhunjhunwala.
Star Health filed its shareholding pattern for the quarter ended June 30, 2026. The filing includes updates regarding the transmission of shares from the late Rakesh Jhunjhunwala.
Sitara Partners LLP acquired 7,82,13,958 shares of Star Health via off-market transfer. The promoter group's total shareholding reached 13.2887%.
Star Health scheduled a board meeting for July 29, 2026. The board will consider unaudited financial results for the quarter ended June 30, 2026.
Star Health announced the retirement of two Independent Directors. Mr. Utpal Sheth was appointed as an Additional Director.
The Estate of Late Rakesh Jhunjhunwala sold its entire 13.05% stake. The transaction was executed off-market via share transmission.
Star Health delivered strong FY26 performance with 13% Insurance Revenue growth and PAT of ₹911cr. Strategy focuses on retail indemnity expertise and digital-first operations.
Star Health Q4 & FY26 results show improved profitability with FY26 PAT at ₹911 Cr (up 16% YoY). Combined ratio improved to 98.8% from 101.1%.
Star Health delivered FY26 GWP of ₹20,369 Cr (16% YoY growth) with an improved Combined Ratio of 98.8%. Strategy focuses on retail indemnity expertise and digital-first operations.
Star Health reported FY26 GWP of ₹20,369 Cr (up 16% YoY) and PAT of ₹911 Cr. Strategy focuses on digital-first onboarding and proprietary agency network growth.
Star Health Q4 & FY26 presentation shows strong turnaround with FY26 PAT at ₹911 Cr (up 16% YoY) and Combined Ratio improving to 98.8%. Strategy focuses on digital onboarding and proprietary agency expansion.